What is Neuroelectrics?
Neuroelectrics operates at the intersection of advanced neuroscience and digital health, specializing in personalized brain stimulation therapy. The company's flagship platform, Starstim, represents a sophisticated cloud-based ecosystem designed for non-invasive neuromodulation. By targeting complex neurological conditions such as epilepsy and depression, Neuroelectrics provides healthcare providers and clinical researchers with high-precision tools for brain monitoring and stimulation. Their methodology relies on proprietary computational models that facilitate tailored treatment protocols, effectively bridging the gap between theoretical neuroscience research and practical, patient-centric clinical applications. This market position is bolstered by a commitment to rigorous data-driven outcomes and scalable cloud infrastructure.
How much funding has Neuroelectrics raised?
Neuroelectrics has raised a total of $17.5M across 1 funding round:
Series A
$17.5M
Series A (2021): $17.5M with participation from Morningside Venture Capital
Key Investors in Neuroelectrics
Morningside Venture Capital
Morningside Venture Capital is a prominent private equity and venture capital firm established in 1986, with a specialized focus on supporting early-stage technology companies through strategic capital and operational guidance.
What's next for Neuroelectrics?
With this major strategic investment, Neuroelectrics is poised to transition from its current development phase into a broader commercial scaling stage. The capital will likely be deployed to enhance the Starstim platform's capabilities, potentially integrating more advanced machine learning algorithms to refine stimulation parameters. Furthermore, the company is expected to prioritize the expansion of its clinical trial portfolio, aiming to secure additional regulatory milestones that will validate its therapeutic efficacy across a wider range of brain disorders. As the firm scales, its focus will remain on solidifying its infrastructure to support enterprise-level adoption among major hospital networks and research institutions, ensuring that its neuromodulation solutions become a standard component of modern neurological care.
See full Neuroelectrics company page
